The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Acetyl-7-((4-(3-isopropyl-2-methyl-2H-indazol-5-yl)-pyrimidin-2-yl)amino)-4-morpholino-2H-chromen-2-one ID: ALA4848734
PubChem CID: 162515863
Max Phase: Preclinical
Molecular Formula: C30H30N6O4
Molecular Weight: 538.61
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)c1c(N2CCOCC2)c2ccc(Nc3nccc(-c4ccc5nn(C)c(C(C)C)c5c4)n3)cc2oc1=O
Standard InChI: InChI=1S/C30H30N6O4/c1-17(2)27-22-15-19(5-8-24(22)34-35(27)4)23-9-10-31-30(33-23)32-20-6-7-21-25(16-20)40-29(38)26(18(3)37)28(21)36-11-13-39-14-12-36/h5-10,15-17H,11-14H2,1-4H3,(H,31,32,33)
Standard InChI Key: RVKNONNXSNALJV-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 45 0 0 0 0 0 0 0 0999 V2000
11.3944 -5.1520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3933 -5.9805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1097 -6.3919 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8276 -5.9800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8248 -5.1484 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1079 -4.7366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5443 -6.3899 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2597 -5.9778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9731 -6.3881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9654 -4.7358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2535 -5.1537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6871 -5.1496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6841 -5.9737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3888 -6.3840 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1052 -5.9790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1082 -5.1549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3948 -4.7358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8191 -6.3935 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.8261 -4.7429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5401 -5.1614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8299 -3.9168 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3966 -3.9097 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1137 -3.5054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1175 -2.6828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4043 -2.2622 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6897 -2.6745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6841 -3.5033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1026 -3.9133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3820 -2.6832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3876 -3.5072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8201 -3.4971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0992 -2.2615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8145 -2.6770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4306 -2.1251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0961 -1.3685 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2733 -1.4529 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5089 -0.6576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2342 -2.2981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4861 -3.0805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7858 -1.6887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 2 0
9 13 1 0
12 10 1 0
10 11 2 0
11 8 1 0
12 13 2 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
15 18 2 0
16 19 1 0
19 20 1 0
19 21 2 0
17 22 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
28 31 2 0
32 29 1 0
29 30 2 0
30 28 1 0
6 28 1 0
33 31 1 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 1 0
36 32 2 0
35 37 1 0
34 38 1 0
38 39 1 0
38 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 538.61Molecular Weight (Monoisotopic): 538.2329AlogP: 5.04#Rotatable Bonds: 6Polar Surface Area: 115.38Molecular Species: NEUTRALHBA: 10HBD: 1#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.67CX Basic pKa: 2.34CX LogP: 4.03CX LogD: 4.03Aromatic Rings: 5Heavy Atoms: 40QED Weighted: 0.23Np Likeness Score: -1.06
References 1. Huang J, Wang X, Dong R, Liu X, Li H, Zhang T, Xu J, Liu C, Zhang Y, Hou S, Tang W, Lu T, Chen Y.. (2021) Discovery of N -(4-(3-isopropyl-2-methyl-2H -indazol-5-yl)pyrimidin-2-yl)-4-(4-methylpiperazin-1-yl)quinazolin-7-amine as a Novel, Potent, and Oral Cyclin-Dependent Kinase Inhibitor against Haematological Malignancies., 64 (17.0): [PMID:34415148 ] [10.1021/acs.jmedchem.1c00271 ]